Butterfly Network (BFLY) Net Equity Issued and Repurchased (2025)
Butterfly Network (BFLY) reported Net Equity Issued and Repurchased of -$103000.0 for Q2 2025, down 100.13% sequentially from $81.1 million in Q1 2025.
Butterfly Network (BFLY) Net Equity Issued and Repurchased (2025) Analysis & Trends
Butterfly Network (BFLY) has 1 years of Net Equity Issued and Repurchased data on file, last reported at -$103000.0 in Q2 2025.
- For the quarter ending Q2 2025, Net Equity Issued and Repurchased changed N/A year-over-year to -$103000.0; the trailing twelve-month figure through Mar 2026 stood at -$103000.0 (down 100.13% YoY), and the FY2025 full-year result was $81.0 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased fell to -$103000.0 in Q2 2025, from $81.1 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $81.1 million in Q1 2025 to a low of -$103000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 12.70 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Butterfly Network | 1.79 Bn | 1.65 Bn | 18.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -103,000.00 |
| Jun 30, 2025 | -103,000.00 |
| Mar 31, 2025 | 81.11 Mn |
| Mar 31, 2025 | 81.11 Mn |